Blogs about BMY - Stockpickr! Your Source for Stock Ideas

Blogs about BMY

Blogs	Description	Date Updated
Stocks Going Ex Dividend Early October	Whenever we are in a bull market, investors use a trading technique called 'Buying Dividends,' which is the technique of buying stocks before the ex dividend date and selling the stock shortly after the ex date at approximately the same price, yet being entitled to the dividend. Please note: this usually only works in rising markets.If you are interested in buying dividends, there are several stocks in several different sectors and industries to choose from. Remember that, in order to be entitle...	September 17, 2008
Fast Money Recap	Financial Take Jeff Macke thinks Lehman should just end the misery and the Fed bailout won’t help anyone. Pete Najarian said the preferred yields on Merrill Lynch (MER) are suggesting that the stock is about to fall big. “If I owned the stock I would be very nervous and buy puts to protect the position,” he added. Joe Terranova said the market doesn’t like the leadership changes among financial companies like American International Group (AIG), Lehman Brothers, Washington Mutual (WM) and...	September 12, 2008
Jim Cramer’s Lightning Round	Bullish Linn Energy (LINE), Bristol-Myers Squibb (BMY) and Bristow Group (BRS). Bearish Inverness Medical (IMA), Pfizer (PFE) and United States Steel (X). Chat and share ideas with the best small cap traders LIVE each day free at Stocknetworkonline.com...	September 08, 2008
Jim Cramer’s Am I Diversified	The first caller had the following stocks: Altria (MO), Bristol-Myers Squibb (BMY), Nike (NKE), General Electric (GE) and Cisco (CSCO). Cramer said he loved this portfolio. The second caller is long the following names: Great Lakes Dredge (GLDD), Darling International (DAR), Frontline (FRO), Tupperware (TUP) and Temple Inland (TIN). Cramer said this portflio is good for this environment. The third caller held these stocks: Coca-Cola (KO), Terra International (TRA), Hewlett-Packard (HPQ), John De...	August 27, 2008
Jim Cramer’s Lightning Round & Sudden Death	Lightning Round Bullish Emerson Electric (EMR), Cisco Systems (CSCO), GrafTech International (GTI), Verizon (VZ), Google (GOOG) and Cummins (CMI). Bearish Terra Nitrogen (TNH), Ambac Financial Group (ABK) and ACCO Brands (ABD). Sudden Death Cramer was bullish on Dawson Geophysica (DWSN), Bristol-Myers Squibb (BMY) and Energen (EGN). Join the fastest growing community of small cap investors at Stockhideout.com...	August 27, 2008
Albany Molecular Research (AMRI): Stock price consolidating in bullish 'pennant'	Filed under: Earnings reports, Bristol-Myers Squibb (BMY), Technical Analysis, Stocks to BuyAlbany Molecular Research (NASDAQ: AMRI) provides contract services to pharmaceutical and biotechnology companies. The firm offers drug discovery, screening programs, libraries for screening and hit-to-lead programs, and analytical quantification of drugs and metabolites in biological samples. The company also conducts its own research, aiming to license its compounds to other firms for further developmen...	August 12, 2008
Icahn's push for better ImClone (IMCL) price may backfire	Filed under: Deals, Microsoft (MSFT), Yahoo! (YHOO), Bristol-Myers Squibb (BMY), ImClone Systems (IMCL)Bristol-Myers Squibb (NYSE: BMY) has made a $60 a share offer for the part of ImClone (NASDAQ: IMCL) that it does not already own. ImClone chairman Carl Icahn does not think tha$60 is high enough, despite ImClone trading below $40 in June. The offer seems like a pretty good deal, and since BMY owns 17% of ImClone , there is not likely to be another bidder. According to The Wall Street Journal,...	August 05, 2008
Icahn & ImClone Merger Game with Bristol-Myers: Bluff vs. Chicken (IMCL, BMY)	Carl Icahn and friends at ImClone Systems Incorporated (NASDAQ: IMCL) have now formally responded to Bristol-Myers Squibb Company (NYSE: BMY) regarding the... [[ This is a content summary only. Visit my website for full links, other content, and more! ]] ...	August 04, 2008
Analyst upgrades, downgrades and initiations	Filed under: Analyst reports, Analyst upgrades and downgrades, Analyst initiationsAnalyst upgrades: Jefferies upgraded shares of Omnicare (NYSE: OCR) to Buy from Hold and raised their target to $37 from $24.50 following the company's Q2 results to reflect improving earnings visibility. Piper upgraded Motorola (NYSE: MOT) to Neutral from Sell following the company's Q2 results to reflect its continued execution in cost management. The firm raised its target to $9 from $7. Capit...	August 01, 2008
Afternoon Reading: Forget Yahoo, Icahn Hits Jackpot With ImClone	Carl Icahn has had his share of misses lately. Yahoo is trading around $20, below where he bought his shares; Motorola is trading at around $8; and of course, his failed attempts to push Biogen Idec into a sale. (See this Mean Street column for more.) But today he scored a hit. Bristol-Myers Squibb proposed acquiring the 83% of ImClone Systems it doesn’t already own for about $4.5 billion. The legendary investor just happens to be ImClone’s largest shareholder and chairman, and the ...	July 31, 2008

Enter search text here: